skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Crystal structure of B-cell co-receptor CD19 in complex with antibody B43 reveals an unexpected fold

Journal Article · · Proteins
DOI:https://doi.org/10.1002/prot.25485· OSTI ID:1433717

Research Organization:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Organization:
INDUSTRY
OSTI ID:
1433717
Journal Information:
Proteins, Vol. 86, Issue 5; ISSN 0887-3585
Publisher:
Wiley
Country of Publication:
United States
Language:
ENGLISH

References (20)

Clinical development of anti-CD19 chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma journal May 2017
CD19 as an attractive target for antibody-based therapy journal September 2012
Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia journal March 2017
Evolution of proteins formed by β-sheets journal September 1982
UniProt: the universal protein knowledgebase journal November 2016
Antibody deficiency due to a missense mutation in CD19 demonstrates the importance of the conserved tryptophan 41 in immunoglobulin superfamily domain formation journal February 2011
Role of CD19 Signal Transduction in B Cell Biology journal January 2002
Canonical structures for the hypervariable regions of immunoglobulins journal August 1987
TanCAR: A Novel Bispecific Chimeric Antigen Receptor for Cancer Immunotherapy journal January 2013
Structural diversity in a human antibody germline library journal May 2016
CD19, from bench to bedside journal March 2017
Construction and characterisation of a functional CD19 specific single chain Fv fragment for immunotherapy of B lineage leukaemia and lymphoma journal November 1997
An Antibody-Deficiency Syndrome Due to Mutations in the CD19 Gene journal May 2006
B cell–directed therapies for autoimmune disease and correlates of disease response and relapse journal January 2008
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy journal January 2012
Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children’s Oncology Group journal January 2015
An anti-CD19 antibody inhibits the interaction between P-glycoprotein (P-gp) and CD19, causes P-gp to translocate out of lipid rafts, and chemosensitizes a multidrug-resistant (MDR) lymphoma cell line journal July 2004
Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells journal October 2009
Phaser crystallographic software journal July 2007
PROCHECK: a program to check the stereochemical quality of protein structures journal April 1993